(Q35899104)
English
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensi
scientific article published on 17 January 2016
Statements
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity (English)
Alexander M M Eggermont
Stefan Suciu
Ulrich Keilholz
Willem H Kruit
Cornelis J Punt
François Salès
Gaetan de Schaetzen
EORTC Melanoma Group